Digital Health Series A Investors & VC Firms
1014 firms in this list, with a median first check of $500K. 301 of them lead rounds. Generated from verified public data and updated continuously.
WILD TREE VENTURES
San JosePre-Seed–Series A$300K
3 people
Woori Venture Partners Us, Inc.
Silicon ValleySeed–Growth
3 people
Aescuvest
Frankfurt am MainSeed–Series B
1 person
HealthTrend Capital
BostonSeed–Late Stage
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
3 people
Global Startup Acceleration Program (JETRO GSAP)
TokyoPre-Seed–Late Stage
Long Hill Capital
Grand CaymanSeries A–Growth
3 people
Remarkable Australia+ Accelerator
SydneyPre-Seed–Series A
Audaxa Ventures
VancouverPre-Seed–Series A
2 people
PTB Ventures
New YorkPre-Seed–Series A
BDC Life Sciences Venture Fund
MontrealSeed–Series A
2 people
First Venture
StockholmSeed–Growth
1 person
HCF Catalyst
SydneySeed–Series A
Krungsri Finnovate
BangkokSeed–Late Stage
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Isenberg Ventures
MontrealSeed–Series A
2 people
Nucleo Ventures
Cluj-NapocaPre-Seed–Series A
2 people
PFM Health Sciences
San FranciscoPre-Seed–Series A
2 people
Shatter
DanvilleSeed–Series A
2 people
Swift Street Capital
DurhamSeed–Series A
2 people
Brain Trust Accelerator Fund
BurlingameSeed–Series A
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
Allegory Capital
GlandSeed–Growth
1 person
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)Series A Investors & VC Firms in Global (2210)
Data sourced from public filings and firms' own websites — see our methodology.

























